Rating History
Dissemination Date Long-Term Rating Short-Term Rating Outlook Action Rating Watch
13-Jun-25 A A1 Stable Maintain -
13-Jun-24 A A1 Stable Maintain -
13-Jun-23 A A1 Stable Maintain -
14-Jun-22 A A1 Stable Maintain -
14-Jun-21 A A1 Stable Upgrade -
About the Entity

Ghani Chemical Industries Limited is a listed entity, incorporated in 2015. Pursuant to the Scheme of Arrangement for merger/amalgamation of G3 Technologies Ltd. with and into Ghani Chemical Industries Ltd., sanctioned by the Lahore High Court vide Order dated October 11, 2022, Pakistan Stock Exchange listed Ghani Chemical Industries Ltd., w.e.f. November 14, 2022. The Company is a subsidiary (~49.07%) of Ghani Global Holdings Limited which is owned majorly by the Ghani Family (~51.89%). The remaining shareholding lies in Ghani ChemWorld Ltd. ~12.27%, directors of the Company and the general public. Members of sponsoring family majorly represent Ghani Chemicals’ four-member board. Mr. Masroor Ahmad Khan is the Chairman of the board while Mr. Hafiz Farooq Ahmad holds the office of CEO. They are assisted by a management team with extensive experience and a diversified skillset.

Rating Rationale

The ratings incorporate the strong business profile of Ghani Chemical Industries Limited (GCIL or "the Company"), underpinned by its leading market share of ~34% in the manufacturing and sale of medical and industrial gases, including Oxygen, Nitrogen, and Argon in both liquid and compressed forms. In addition to its core gases business, GCIL is also engaged in import and sale of Calcium Carbide, a chemical primarily used in the food ripening process and as a critical raw material in various chemical manufacturing industries. Chemical segment contributes around 15% to the Company’s total revenue and to enhance operational focus and align with its strategic objective of import substitution, GCIL has recently carved out its Calcium Carbide business into a newly established entity, Ghani ChemWorld Limited (GCWL), which is now listed on the Pakistan Stock Exchange (PSX). As part of this corporate restructuring, all assets and liabilities associated with the Calcium Carbide segment have been transferred from GCIL to GCWL. The demerger process, including all regulatory and legal formalities, has been completed. The newly formed GCWL will operate a dedicated local manufacturing facility with a planned production capacity of 75 tons per day (TPD), located in the Hattar Special Economic Zone. Currently, Ghani Chemical Industries Limited (GCIL) operates four production facilities (ASUs)—two located in Lahore and two at Port Qasim, Karachi—achieving an overall capacity utilization of ~67% as of IHFY25. In a significant expansion initiative, GCIL has launched Pakistan’s largest industrial and medical gases plant at the Hattar Special Economic Zone, with a production capacity of 275 TPD and presently in its trial run phase. Additionally, the Company is in the advanced stages of securing approvals to relocate one of its Lahore-based plants to Oman, aiming to cater to the rising demand from the medical sector in the region. The performance of the industrial and medical gases sector remains closely tied to the ongoing development of healthcare infrastructure and the revival of Large-Scale Manufacturing (LSM). With the recent stabilization of the exchange rate, a gradual decline in inflation, and easing policy rates, the sector is well-positioned to benefit from improving macroeconomic conditions. During 9MFY25, the Company recorded revenue of ~PKR 5.3bln, reflecting a year-on-year growth of around ~31%. This growth was primarily driven by an optimized pricing strategy, which contributed to margin improvement across all levels of operations. GCIL operates under the oversight of a strategic governing board and an experienced management team. The financial risk profile of the Company is considered good with comfortable coverages, cashflows, and working capital cycle. The Company's capital structure is leveraged, with borrowings consisting of long-term debt to support expansion and short-term debt for working capital management.

Key Rating Drivers

The ratings are dependent on the Company's ability to effectively utilize enhanced capacities. At the same time, management of financial risk, particularly debt coverages, remains important. Consistent growth in market share and improved margins would support ratings.

Profile
Legal Structure

Ghani Chemical Industries Limited was originally incorporated as a Private Limited Company on November 23, 2015, under the now-repealed Companies Ordinance, 1984 (currently replaced by the Companies Act, 2017). It transitioned to a Public Limited Company on April 20, 2017, and was officially listed on the Pakistan Stock Exchange (PSX) on November 14, 2022. The Company’s Registered Office is located at 10-N Model Town Extension, Lahore, with production facilities operating in Phool Nagar, District Kasur, and the Industrial Zone at Port Qasim, Karachi.


Background

In July 2019, under the Scheme of Compromises, Arrangements, and Reconstruction initiated by the Ghani Global Group, the manufacturing operations of Ghani Gases Limited, including all associated assets and liabilities, were transferred to Ghani Chemical Industries Limited. The Company now operates as a subsidiary of Ghani Global Holdings Limited (formerly known as Ghani Gases Limited).


Operations

Ghani Chemical Industries Limited specializes in the manufacturing, sale, and trading of medical and industrial gases and chemicals, including Liquid Nitrogen, Liquid Oxygen and Argon. The Company’s total production capacity now stands at approximately ~435 tons per day (TPD). However, once Hattar plant is operational, capacity would increase to ~710TPD.


Ownership
Ownership Structure

The majority stake in Ghani Chemical Industries Limited is currently held by its parent Company_Ghani Global Holdings Limited, which is primarily owned by the Ghani Family, holding approximately ~49.07% of the shares. The remaining shareholding lies in Ghani ChemWorld Ltd. ~12.27%, directors of the Company and the general public.


Stability

The restructuring undertaken by the Ghani Group in January 2020 marked a significant shift in the Company's strategic direction. Through this initiative, Ghani Gases Limited transitioned from being a manufacturing-focused entity to becoming the holding Company of the Group, now operating under the name Ghani Global Holdings Limited. This transformation likely reflects the Group's ambition to expand its reach and diversify its portfolio by focusing on managing investments and overseeing its subsidiaries. By consolidating operations and adopting the role of a holding Company, Ghani Global Holdings Limited is better positioned to explore new opportunities for growth and innovation across various industries.


Business Acumen

The sponsors possess an impressive legacy of entrepreneurial expertise, having accumulated over five decades of experience across a wide spectrum of industries. Their diverse business portfolio encompasses key sectors such as industrial gases, engineering, mining, glass manufacturing, real estate, automobiles, and food, reflecting their ability to navigate and excel in multiple domains. Through this extensive exposure, they have developed a robust foundation in strategic expansion, innovation, and market leadership. Their ability to identify emerging opportunities, adapt to industry trends, and foster sustainable growth has solidified their position as influential figures in the business world. This breadth of experience not only underscores their leadership capabilities but also highlights their deep understanding of economic dynamics, ensuring a lasting impact across various industries.


Financial Strength

As of May 31, 2025, the Ghani Group—which comprises Ghani Global Holdings Limited, Ghani Global Glass Limited, Ghani Chemical Industries Limited and newly established Ghani ChemWorld Ltd—reported total equity of PKR ~18.6bn. The Group has demonstrated strong financial capability and a consistent willingness to support the Company.


Governance
Board Structure

Ghani Chemical Industries Limited is governed by a seven-member Board of Directors, chaired by Mr. Masroor Ahmad Khan. The Board comprises six members from the sponsoring family, including the Chief Executive Officer (CEO), and one representative from the Group’s employees, fostering internal alignment and continuity in leadership.To further enhance governance and ensure objective oversight, the Board also includes two independent directors, Mr. Mahmood Ahmad and Mr. Hafiz Imran Latif. Their presence brings valuable external perspectives, reinforcing strategic decision-making and fostering a balanced, transparent approach to corporate leadership. This governance structure enables the Company to maintain stability while driving innovation and sustainable growth.


Members’ Profile

Mr. Masroor Ahmad Khan, the Chairman, has played a pivotal role in the family business since 1985, demonstrating exceptional leadership and industry expertise over the decades. His deep involvement has contributed significantly to the Company’s steady growth and strategic direction. Most of the Company's directors have been serving since the Board’s inception, bringing diverse experience from multiple industries. Their long-standing tenure fosters stability, informed decision-making, and a keen understanding of the Company’s operations. This continuity ensures that Ghani Chemical Industries Limited remains resilient, adaptive, and well-positioned for sustained success in an evolving business landscape.


Board Effectiveness

Ghani Chemical Industries Limited holds its board meetings on a quarterly basis, strictly following corporate governance principles applicable to publicly listed Companies. These meetings play a vital role in maintaining effective oversight, facilitating strategic decision-making, and ensuring the Company’s long-term sustainability in a dynamic business environment. To uphold transparency and regulatory compliance, the minutes of each meeting are meticulously documented and preserved. This diligent record-keeping not only strengthens corporate accountability but also fosters trust among stakeholders, ensuring that key decisions align with the Company’s vision and industry best practices.


Financial Transparency

M/s ShineWing Hameed Chaudhri & Co. Chartered Accountants serves as the external auditor for Ghani Chemical Industries Limited. The firm is QCR-listed and is also on the State Bank of Pakistan’s panel of approved auditors. They conducted a special audit of the Company in February 2025, to smooth the demerger process by ensuring compliance with regulatory standards and providing independent assurance on the Company's financial practices. Auditors have expressed the unqualified report on financial statements of the Company as on FY24.


Management
Organizational Structure

Ghani Chemical Industries Limited operates through a well-structured framework comprising six key functional divisions, each led by a dedicated divisional head who reports directly to the Chief Executive Officer. This strategic organizational model fosters operational efficiency, enhances communication, and ensures cohesive alignment with the Company’s broader vision and objectives. By overseeing their respective domains, the divisional heads play a vital role in driving performance optimization, implementing innovative initiatives, and steering their departments toward sustainable growth. Their leadership contributes to a dynamic, well-coordinated operational environment, enabling the Company to navigate industry challenges while maintaining a competitive edge. This structured approach not only streamlines management but also reinforces accountability, collaboration, and strategic execution across all levels of the organization.


Management Team

Mr. Hafiz Farooq Ahmad serves as the Chief Executive Officer of Ghani Chemical Industries Limited, steering the Company with visionary leadership and a commitment to excellence. Under his guidance, the management team consists of highly skilled and experienced professionals, each bringing deep expertise not only in the industrial gases sector but also across various other industries. This dynamic and diverse leadership team plays a crucial role in shaping the Company's strategic direction, optimizing operational efficiency, and driving sustainable growth. Their collective knowledge and strategic insights enable Ghani Chemical Industries Limited to navigate industry challenges effectively, seize emerging opportunities, and maintain its competitive edge in an evolving market landscape. Through innovation, collaboration, and a results-driven approach, the leadership continues to strengthen the Company’s foundation for long-term success.


Effectiveness

Ghani Chemical Industries Limited upholds a strong and secure IT infrastructure, equipped with comprehensive controls to ensure seamless system operations and data security. The Company prioritizes technological integrity, implementing advanced measures to safeguard critical information and optimize efficiency across its digital platforms. To maintain informed leadership and promote strategic decision-making, regular reports are presented to senior management, providing insights that drive data-driven business strategies. Additionally, specialized management committees are established to oversee key operational challenges, ensuring that relevant issues are addressed proactively. The meticulous documentation of meeting minutes reinforces transparency, accountability, and regulatory compliance, strengthening the organization's governance framework. This structured approach enables the Company to remain agile, resilient, and well-positioned for future advancements in the digital landscape.


MIS

The Company has implemented an advanced Oracle ERP solution, significantly enhancing the quality and efficiency of its reporting system. This integration has streamlined operations, improved data accuracy, and provided management with real-time insights for better decision-making and strategic planning. Additionally, the ERP system supports seamless communication and collaboration across various departments, contributing to the overall effectiveness of the Company's business processes.


Control Environment

Management Information System (MIS) reports play a vital role in Ghani Chemical Industries Limited's operational oversight, covering critical areas such as inventory management, finance, production, sales, and overall business operations. These reports are regularly presented to senior management, ensuring data-driven decision-making that enhances efficiency and strategic direction. To further strengthen its technological capabilities, the Company has integrated Oracle technology into its database system. This integration ensures the timely availability and accessibility of essential business information, facilitating seamless workflows and informed leadership decisions. By leveraging advanced data management tools, Ghani Chemical Industries Limited optimizes operational effectiveness, improves financial planning, and enhances long-term business sustainability. This robust digital infrastructure reinforces the Company's commitment to innovation, efficiency, and strategic excellence.


Business Risk
Industry Dynamics

The industrial gases sector in Pakistan is experiencing steady growth, driven by increasing demand across healthcare, manufacturing, and metallurgy. The country relies heavily on oxygen, nitrogen, and carbon dioxide for applications in steel production, food processing, and medical treatments. Sustainability is becoming a key focus, with Companies investing in efficient gas production technologies to reduce environmental impact. The healthcare industry, particularly hospitals and pharmaceutical firms, continues to be a major consumer of medical gases like oxygen and nitrogen. Pakistan’s industrial expansion, including infrastructure projects and energy developments, is fueling demand for specialized gases. Additionally, advancements in gas separation and distribution are improving efficiency, ensuring a stable supply chain for various industries. The prices of industrial gases are primarily influenced by market dynamics, including energy costs, fluctuations in oil and natural gas prices, the quality of specialty gases, and the customization of products. The overall production capacity for industrial gases currently stands at approximately 1,300 tons per day (TPD), with significant contributions from Ghani Chemical Industries and Pakistan Oxygen (formerly Linde Pakistan). Pakistan Oxygen's total production capacity is 533 TPD, of which 430 TPD is currently operational. In comparison, Ghani Chemical Industries has a total production capacity of around 435 TPD. However, once Hattar plant of Ghani Chemical's is operational, capacity would increase to ~710TPD.




Relative Position

The industrial gases sector in Pakistan is highly competitive, with Pakistan Oxygen currently leading the market with an estimated ~40% share. Ghani Chemical Industries follows closely, holding approximately ~34% of the market and poised for significant growth. With the upcoming launch of its new production facility, Ghani Chemicals is set to strengthen its market position, potentially reshaping the industry’s competitive dynamics. Other players in the sector have comparatively limited production capacities, leading to a smaller overall presence. Ghani Chemical Industries is spearheading transformative projects, including the establishment of Pakistan's largest Air Separation Unit (ASU) in the Hattar Special Economic Zone, Khyber Pakhtunkhwa. Scheduled to become operational by end of May 2025, this cutting-edge facility will produce 275 tons of medical and industrial gases daily, addressing rising demand. Additionally, Ghani Chemical is developing a calcium carbide manufacturing project in the same economic zone, which aims to reduce dependency on imports and contribute to foreign exchange earnings. These initiatives highlight the sector's pivotal role in supporting industries like healthcare, manufacturing, and energy, while also driving economic efficiency and creating employment opportunities.


Revenues

The Company's revenue growth is predominantly fueled by its industrial gases segment, with Liquid Oxygen and Liquid Nitrogen being the key contributors. During 9MFY25, the Company recorded net sales of PKR 5,334mln, demonstrating a substantial year-over-year (YoY) growth of ~31% compared to the PKR 5,437mln achieved in FY24. This positive trajectory underscores strong market demand, particularly within sectors such as healthcare, manufacturing, and energy, which have seen an uptick in industrial gas consumption. Additionally, the growth signals improved operational efficiency, likely supported by capacity expansion and optimized production processes, enabling the Company to enhance supply chain performance and meet rising customer needs. These factors collectively contribute to the Company’s financial strength and competitive positioning, reinforcing its ability to capitalize on industry trends and sustain long-term profitability.



Margins

The Company demonstrated a substantial improvement in its profitability metrics, with gross margins increasing to ~47% in 9MFY25, up from ~29.7% in FY24. This remarkable growth highlights the success of optimized pricing strategies, which allowed for better cost recovery and revenue enhancement. Additionally, net margins saw a significant uplift, reaching ~23% in 9MFY25 compared to ~14.5% in FY24. This improvement was primarily driven by effective cost management initiatives and the implementation of operational efficiencies that streamlined processes and reduced overhead costs. The combined effect of these strategic measures underscores the Company’s commitment to financial optimization, ensuring higher profitability while maintaining a competitive edge in the market.


Sustainability

GCIL has recently carved out its Calcium Carbide business into a newly established entity, Ghani Chemworld Limited (GCL), which is now listed on the Pakistan Stock Exchange (PSX). As part of this corporate restructuring, all assets and liabilities associated with the Calcium Carbide segment have been transferred from GCIL to GCL. The demerger process, including all regulatory and legal formalities, has been completed. The newly formed GCL will operate a dedicated local manufacturing facility with a planned production capacity of 75 tons per day (TPD), located in the Hattar Special Economic Zone.The financial benefits anticipated from the new plant’s operations, including increased revenue and improved gross margins, have yet to materialize. Company is also proactively pursuing several new contracts, which are currently in the negotiation and development stages. These agreements are expected to play a crucial role in strengthening financial stability by ensuring steady revenue streams and enhanced profitability. Additionally, securing long-term partnerships will help mitigate risks associated with fluctuating demand and provide a solid foundation for sustained growth. While short-term financial gains may take time, these strategic efforts demonstrate a forward-looking approach, ensuring the Company is well-positioned for future expansion and operational efficiency.


Financial Risk
Working capital

In 9MFY25, the Company's inventory days reached to ~9days (FY24: ~8 days), reflecting a well-managed working cycle to meet upcoming demand efficiently. However, trade receivable days increased to around ~114 days (FY24: ~106 days), primarily due to extended credit terms and delayed payments from key clients. Gross working capital days also increased to  ~123 days (FY24: ~114 days). Trade payable days declined to ~6 days in 9MFY25 (FY24: ~10 days), as the Company likely settled supplier payments faster to maintain favorable vendor relationships.  As a result, net working capital days also increased to ~118 days (FY24: ~104 days), indicating a longer cash conversion cycle. While this trend underscores the Company's ability to support growth through extended receivables and optimized payables, it also highlights the need for robust financial controls to ensure sustainability in cash flow management.


Coverages

In 9MFY25, Ghani Chemical Industries Limited experienced a decline in free cash flows (FCFO), falling to negative PKR -219mln, compared to PKR 1,573mln in FY24. This drop was primarily due to demerger adjustments_ Ghani Chemworld Ltd., which impacted liquidity, alongside a higher finance cost, reflecting increased borrowing expenses. The interest coverage ratio also declined, reaching negative -0.7x in 9MFY25, a significant decrease from ~4.2x in FY24. This shift suggests that the Company faced challenges in covering its interest obligations, likely due to rising financing costs and increased leverage. Similarly, the debt coverage ratio deteriorated to negative -2.6x in 9MFY25, down from ~2.4x in FY24, highlighting increased debt pressure on cash flow availability. These financial indicators underscore the impact of strategic restructuring and higher borrowing costs on the Company’s liquidity position. While expansion efforts and capital restructuring can drive future growth, effective financial management will be crucial in restoring cash flow stability and improving debt servicing capacity.


Capitalization

In 9MFY25, Ghani Chemicals experienced an increase in leverage, rising to ~35%, compared to ~31% in FY24. This uptick was primarily driven by higher borrowings, which were necessary to finance the Company’s expansion initiatives and meet its working capital requirements. A notable shift was observed in the composition of borrowings, with short-term financing accounting for ~58% of total borrowings in 9MFY25, a significant rise from ~35% in FY24. This strategic move toward short-term debt was likely intended to enhance financial agility, allowing the Company to respond more efficiently to operational needs and market fluctuations. While short-term financing offers flexibility, it can also lead to higher refinancing risks and interest costs, necessitating careful management to maintain liquidity and long-term financial stability.


 
 

Jun-25

www.pacra.com


Mar-25
9M
Jun-24
12M
Jun-23
12M
Jun-22
12M
A. BALANCE SHEET
1. Non-Current Assets 9,804 11,185 7,778 6,404
2. Investments 0 0 0 0
3. Related Party Exposure 1,321 1,242 1,777 1,695
4. Current Assets 4,373 4,454 3,573 3,338
a. Inventories 206 161 79 135
b. Trade Receivables 2,302 2,142 1,021 825
5. Total Assets 15,497 16,881 13,128 11,436
6. Current Liabilities 1,575 1,610 775 661
a. Trade Payables 172 60 253 135
7. Borrowings 4,482 4,514 2,811 2,669
8. Related Party Exposure 0 0 0 0
9. Non-Current Liabilities 1,066 903 712 501
10. Net Assets 8,374 9,854 8,830 7,605
11. Shareholders' Equity 8,374 9,854 8,830 7,605
B. INCOME STATEMENT
1. Sales 5,334 5,437 4,332 4,214
a. Cost of Good Sold (2,833) (3,825) (2,872) (2,465)
2. Gross Profit 2,501 1,613 1,460 1,749
a. Operating Expenses (320) (387) (409) (491)
3. Operating Profit 2,181 1,226 1,051 1,258
a. Non Operating Income or (Expense) 101 448 255 197
4. Profit or (Loss) before Interest and Tax 2,282 1,674 1,306 1,455
a. Total Finance Cost (315) (389) (374) (230)
b. Taxation (740) (499) (424) (355)
6. Net Income Or (Loss) 1,227 786 508 870
C. CASH FLOW STATEMENT
a. Free Cash Flows from Operations (FCFO) (219) 1,573 1,226 1,263
b. Net Cash from Operating Activities before Working Capital Changes (662) 1,573 1,226 1,263
c. Changes in Working Capital (251) 143 (1,190) (392)
1. Net Cash provided by Operating Activities (912) 1,715 37 871
2. Net Cash (Used in) or Available From Investing Activities 1,222 (3,307) (412) (765)
3. Net Cash (Used in) or Available From Financing Activities (319) 1,535 46 685
4. Net Cash generated or (Used) during the period (10) (56) (330) 792
D. RATIO ANALYSIS
1. Performance
a. Sales Growth (for the period) 30.8% 25.5% 2.8% 9.8%
b. Gross Profit Margin 46.9% 29.7% 33.7% 41.5%
c. Net Profit Margin 23.0% 14.5% 11.7% 20.7%
d. Cash Conversion Efficiency (FCFO adjusted for Working Capital/Sales) -8.8% 31.5% 0.8% 20.7%
e. Return on Equity [ Net Profit Margin * Asset Turnover * (Total Assets/Shareholders' Equity )] 18.0% 8.4% 6.2% 16.6%
2. Working Capital Management
a. Gross Working Capital (Average Days) 123 114 87 76
b. Net Working Capital (Average Days) 118 104 70 66
c. Current Ratio (Current Assets / Current Liabilities) 2.8 2.8 4.6 5.0
3. Coverages
a. EBITDA / Finance Cost 0.1 4.8 4.0 6.4
b. FCFO / Finance Cost+CMLTB+Excess STB -0.4 1.8 1.6 2.1
c. Debt Payback (Total Borrowings+Excess STB) / (FCFO-Finance Cost) -2.6 2.4 2.0 1.3
4. Capital Structure
a. Total Borrowings / (Total Borrowings+Shareholders' Equity) 34.9% 31.4% 24.1% 26.0%
b. Interest or Markup Payable (Days) 180.9 326.8 122.9 136.6
c. Entity Average Borrowing Rate 9.1% 10.0% 12.7% 8.9%

Jun-25

www.pacra.com

Jun-25

www.pacra.com

  1. Rating Team Statements
    1. Rating is just an opinion about the creditworthiness of the entity and does not constitute a recommendation to buy, hold, or sell any security of the entity rated or to buy, hold, or sell the security rated, as the case may be. (Chapter III; 14-3-(x))
    2. Conflict of Interest
      1. The Rating Team or any of their family members have no interest in this rating (Chapter III; 12-2-(j))
      2. PACRA, the analysts involved in the rating process, and members of its rating committee and their family members do not have any conflict of interest relating to the rating done by them (Chapter III; 12-2-(e) & (k))
      3. The analyst is not a substantial shareholder of the customer being rated by PACRA [Annexure F; d-(ii)]
      4. Explanation: for the purpose of the above clause, the term "family members" shall include only those family members who are dependent on the analyst and members of the rating committee.
  2. Restrictions
    1. No director, officer, or employee of PACRA communicates the information acquired by him for use for rating purposes to any other person, except where required under law to do so. (Chapter III; 10-(5))
    2. PACRA does not disclose or discuss with outside parties or make improper use of the non-public information which has come to its knowledge during a business relationship with the customer. (Chapter III; 10-7-(d))
    3. PACRA does not make proposals or recommendations regarding the activities of rated entities that could impact a credit rating of the entity subject to rating. (Chapter III; 10-7-(k))
  3. Conduct of Business
    1. PACRA fulfills its obligations in a fair, efficient, transparent, and ethical manner and renders high standards of services in performing its functions and obligations. (Chapter III; 11-A-(a))
    2. PACRA uses due care in the preparation of this Rating Report. Our information has been obtained from sources we consider to be reliable, but its accuracy or completeness is not guaranteed. PACRA does not, in every instance, independently verify or validate information received in the rating process or in preparing this Rating Report. (Clause 11-(A)(p))
    3. PACRA prohibits its employees and analysts from soliciting money, gifts, or favors from anyone with whom PACRA conducts business. (Chapter III; 11-A-(q))
    4. PACRA ensures before the commencement of the rating process that an analyst or employee has not had a recent employment or other significant business or personal relationship with the rated entity that may cause or may be perceived as causing a conflict of interest. (Chapter III; 11-A-(r))
    5. PACRA maintains the principle of integrity in seeking rating business. (Chapter III; 11-A-(u))
    6. PACRA promptly investigates in the event of misconduct or a breach of the policies, procedures, and controls, and takes appropriate steps to rectify any weaknesses to prevent any recurrence, along with suitable punitive action against the responsible employee(s). (Chapter III; 11-B-(m))
  4. Independence & Conflict of Interest
    1. PACRA receives compensation from the entity being rated or any third party for the rating services it offers. The receipt of this compensation has no influence on PACRA’s opinions or other analytical processes. In all instances, PACRA is committed to preserving the objectivity, integrity, and independence of its ratings. Our relationship is governed by two distinct mandates: i) rating mandate - signed with the entity being rated or issuer of the debt instrument, and ii) fee mandate - signed with the payer, which can be different from the entity.
    2. PACRA does not provide consultancy/advisory services or other services to any of its customers or their associated companies and associated undertakings that are being rated or have been rated by it during the preceding three years, unless it has an adequate mechanism in place ensuring that the provision of such services does not lead to a conflict of interest situation with its rating activities. (Chapter III; 12-2-(d))
    3. PACRA discloses that no shareholder directly or indirectly holding 10% or more of the share capital of PACRA also holds directly or indirectly 10% or more of the share capital of the entity which is subject to rating or the entity which issued the instrument subject to rating by PACRA. (Chapter III; 12-2-(f))
    4. PACRA ensures that the rating assigned to an entity or instrument is not affected by the existence of a business relationship between PACRA and the entity or any other party, or the non-existence of such a relationship. (Chapter III; 12-2-(i))
    5. PACRA ensures that the analysts or any of their family members shall not buy, sell, or engage in any transaction in any security which falls in the analyst’s area of primary analytical responsibility. This clause, however, does not apply to investments in securities through collective investment schemes. (Chapter III; 12-2-(l))
    6. PACRA has established policies and procedures governing investments and trading in securities by its employees and for monitoring the same to prevent insider trading, market manipulation, or any other market abuse. (Chapter III; 11-B-(g))
  5. Monitoring and Review
    1. PACRA monitors all the outstanding ratings continuously, and any potential change therein due to any event associated with the issuer, the security arrangement, the industry, etc., is disseminated to the market immediately and in an effective manner after appropriate consultation with the entity/issuer. (Chapter III; 17-(a))
    2. PACRA reviews all the outstanding ratings periodically on an annual basis. Provided that public dissemination of annual review and in an instance of change in rating will be made. (Chapter III; 17-(b))
    3. PACRA initiates an immediate review of the outstanding rating upon becoming aware of any information that may reasonably be expected to result in downgrading of the rating. (Chapter III; 17-(c))
    4. PACRA engages with the issuer and the debt securities trustee to remain updated on all information pertaining to the rating of the entity/instrument. (Chapter III; 17-(d))
  6. Probability of Default
    1. PACRA’s Rating Scale reflects the expectation of credit risk. The highest rating has the lowest relative likelihood of default (i.e., probability). PACRA’s transition studies capture the historical performance behavior of a specific rating notch. Transition behavior of the assigned rating can be obtained from PACRA’s Transition Study available at our website. (www.pacra.com) However, the actual transition of rating may not follow the pattern observed in the past. (Chapter III; 14-3(f)(vii))
  7. Proprietary Information
    1. All information contained herein is considered proprietary by PACRA. Hence, none of the information in this document can be copied or otherwise reproduced, stored, or disseminated in whole or in part in any form or by any means whatsoever by any person without PACRA’s prior written consent.

Jun-25

www.pacra.com